Compare Stocks

→ What is the 72-Hour Profit Surge? (From DTI) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AIF Apollo Tactical Income Fund	$14.00 -0.8%	$14.62	$11.95 ▼ $15.45	N/A	N/A	139,994 shs	80,819 shs
CAPC Capstone Companies	$0.01 -21.8%	$0.01	$0.01 ▼ $0.06	$551K	-0.37	22,959 shs	5,700 shs
DJAN FT Vest U.S. Equity Deep Buffer ETF - January	$35.61 +0.1%	$35.66	$0.00 ▼ $0.00	$262.82M	0.48	N/A	16,449 shs
GRI GRI Bio	0.43 -1.6%	0.73	0.41 ▼ 62.23	$1.38M	-1.77	602,751 shs	25,075 shs

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AIF Apollo Tactical Income Fund	-1.12%	-1.26%	+2.39%	-1.47%	+15.17%
CAPC Capstone Companies	+27.93%	+17.36%	+10.94%	-47.01%	-68.72%
DJAN FT Vest U.S. Equity Deep Buffer ETF - January	+0.12%	+0.63%	-0.86%	+2.04%	+14.70%
GRI GRI Bio	-2.13%	-14.24%	-43.59%	-77.64%	+43,739,900.00%

These AI trades triggered this morning (545% return) (Ad)

If you think a market crash is possible in 2024, I don't know why you're not using this yet.

Click Here To Get Your Free Copy

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AIF Apollo Tactical Income Fund	1.0574 of 5 stars	3.0	2.0	0.0	0.0	0.0	0.8	0.0
CAPC Capstone Companies	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
DJAN FT Vest U.S. Equity Deep Buffer ETF - January	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
GRI GRI Bio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AIF Apollo Tactical Income Fund	2.00	Hold	$52.50	275.00% Upside
CAPC Capstone Companies	N/A	N/A	N/A	N/A
DJAN FT Vest U.S. Equity Deep Buffer ETF - January	0.00	N/A	N/A	N/A
GRI GRI Bio	N/A	N/A	N/A	N/A

Current Analyst Ratings

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AIF Apollo Tactical Income Fund	$36.81M	N/A	N/A	N/A	N/A	N/A
CAPC Capstone Companies	$190K	2.90	N/A	N/A	($0.05) per share	-0.22
DJAN FT Vest U.S. Equity Deep Buffer ETF - January	N/A	N/A	N/A	N/A	N/A	N/A
GRI GRI Bio	N/A	N/A	N/A	N/A	0.40 per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AIF Apollo Tactical Income Fund	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
CAPC Capstone Companies	-$1.70M	-$0.04	N/A	∞	N/A	-879.28%	N/A	-100.71%	N/A
DJAN FT Vest U.S. Equity Deep Buffer ETF - January	N/A	N/A	23.44	∞	N/A	N/A	N/A	N/A	N/A
GRI GRI Bio	-$13.04M	-81.48	N/A	∞	N/A	N/A	-795.54%	-345.37%	5/20/2024 (Estimated)

Latest DJAN, CAPC, AIF, HLCL, and GRI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/29/2024	Q4 2023	CAPC Capstone Companies	N/A	-$0.01	-$0.01	-$0.01	N/A	$0.10 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AIF Apollo Tactical Income Fund	$1.54	11.00%	+15.51%	N/A	2 Years
CAPC Capstone Companies	N/A	N/A	N/A	N/A	N/A
DJAN FT Vest U.S. Equity Deep Buffer ETF - January	N/A	N/A	N/A	N/A	N/A
GRI GRI Bio	N/A	N/A	N/A	N/A	N/A

Latest DJAN, CAPC, AIF, HLCL, and GRI Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/12/2024	AIF Apollo Tactical Income Fund	Monthly	$0.1440	12.33%	4/22/2024	4/23/2024	4/30/2024
3/11/2024	AIF Apollo Tactical Income Fund	Monthly	$0.1380	11.04%	3/20/2024	3/21/2024	3/28/2024
2/9/2024	AIF Apollo Tactical Income Fund	Monthly	$0.1330	10.99%	2/21/2024	2/22/2024	2/29/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AIF Apollo Tactical Income Fund	N/A	N/A	N/A
CAPC Capstone Companies	N/A	0.02	0.02
DJAN FT Vest U.S. Equity Deep Buffer ETF - January	N/A	N/A	N/A
GRI GRI Bio	N/A	1.09	1.09

Ownership

Institutional Ownership

Company	Institutional Ownership
AIF Apollo Tactical Income Fund	N/A
CAPC Capstone Companies	N/A
DJAN FT Vest U.S. Equity Deep Buffer ETF - January	N/A
GRI GRI Bio	33.95%

Insider Ownership

Company	Insider Ownership
AIF Apollo Tactical Income Fund	N/A
CAPC Capstone Companies	40.00%
DJAN FT Vest U.S. Equity Deep Buffer ETF - January	N/A
GRI GRI Bio	16.82%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
AIF Apollo Tactical Income Fund	N/A	N/A	N/A	Not Optionable
CAPC Capstone Companies	5	49.64 million	29.79 million	Not Optionable
DJAN FT Vest U.S. Equity Deep Buffer ETF - January	N/A	7.38 million	N/A	Not Optionable
GRI GRI Bio	1	3.20 million	2.66 million	Not Optionable

DJAN, CAPC, AIF, HLCL, and GRI Headlines

Source	Headline
	GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar globenewswire.com - April 25 at 9:15 AM
	GRI Bio (NASDAQ:GRI) Stock Price Down 2.8% americanbankingnews.com - April 24 at 3:00 AM
	GRI Bio, Inc.: GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea Patent finanznachrichten.de - April 18 at 7:33 PM
	GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea Patent globenewswire.com - April 16 at 8:35 AM
	GRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International Conference globenewswire.com - April 8 at 8:35 AM
	GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate Update globenewswire.com - April 1 at 7:35 AM
	Tamil Nadu Newsprint & Papers Share Price business-standard.com - March 28 at 7:19 PM
	Steven Ehrlich donates professional archive to Architecture and Design Collection at UCSB’s AD&A Museum archpaper.com - March 28 at 7:19 PM
	GRI Bio to Present at the MedInvest Biotech & Pharma Investor Conference globenewswire.com - March 28 at 9:00 AM
	UCSB Art Museum Collection adds Archive of Modernist Architect Steven Ehrlich noozhawk.com - March 18 at 9:11 PM
	Prominent Modernist Steven Ehrlich Adds Architectural Archives to UC Santa Barbara Art Museum independent.com - March 15 at 8:03 PM
	GRI Bio, Inc.: GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulators finanznachrichten.de - March 14 at 1:50 PM
	GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulators finance.yahoo.com - March 14 at 8:50 AM
	GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulators globenewswire.com - March 14 at 8:45 AM
	GRI Bio, Inc.: GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United Kingdom finanznachrichten.de - March 4 at 12:43 PM
	GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United Kingdom globenewswire.com - March 4 at 8:30 AM
	Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI) benzinga.com - February 23 at 7:50 AM
	GRI Bio: Entry Into A Material Definitive Agreement, Other Events cbonds.com - February 5 at 2:06 PM
	GRI Bio Launches Major Securities Public Offering msn.com - February 3 at 2:55 PM
	GRI Bio prices 5M shares at $1.10 in public offering msn.com - February 2 at 12:29 PM
	GRI Bio Shares Drop After Stock Offering Prices Below Thursday's Close marketwatch.com - February 2 at 12:29 PM
	GRI Bio Announces Pricing Of $5.5 Mln Public Offering, Stock Down markets.businessinsider.com - February 2 at 12:29 PM
	Why Is GRI Bio (GRI) Stock Down 21% Today? investorplace.com - February 2 at 11:07 AM
	Samsung Galaxy Fit3 tüm ayrıntılarıyla belli oldu: İşte özellikleri donanimhaber.com - January 31 at 12:56 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Apollo Tactical Income Fund

NYSE:AIF

Apollo Tactical Income Fund Inc. is a closed-ended fixed income fund launched and managed by Apollo Credit Management, LLC. The fund invests in fixed income markets. It primarily invests in senior secured loans including floating rate senior loans, high yield corporate bonds, and other credit instruments of varying maturities made to companies whose debt is typically rated below investment grade. The fund employs a conservative approach to credit selection that focuses on such factors as collateral coverage, structural seniority, credit fundamentals, with emphasis on leading defensible market positions, stable companies with positive cash flow, and proven management teams to create its portfolio. Apollo Tactical Income Fund Inc. was formed on February 25, 2013 and is domiciled in the United States.

Capstone Companies

OTCMKTS:CAPC

Capstone Companies, Inc., through its subsidiaries, engages in the development, marketing, and sale of consumer home light-emitting diode (LED) lighting products for indoor and outdoor applications worldwide. Its lighting products include connected surfacessmart mirrors and standard rectangular wardrobe/fitness mirrors. The company markets its products under the Capstone Lighting brand name, as well as under the Hoover Home LED brand through a network of direct sales force, retailers, and distributors. It sells its products through e-commerce websites. The company was formerly known as CHDT Corporation and changed its name to Capstone Companies, Inc. in June 2012. Capstone Companies, Inc. is headquartered in Deerfield Beach, Florida.

FT Vest U.S. Equity Deep Buffer ETF - January

BATS:DJAN

The FT Cboe Vest U.S. Equity Deep Buffer ETF - January (DJAN) is an exchange-traded fund that is based on the SPDR S&P 500 ETF Trust index. The fund aims for specific buffered losses and capped gains on SPY ETF over a specific holdings period. The actively-managed fund holds options and collateral. DJAN was launched on Jan 15, 2021 and is managed by First Trust.

GRI Bio

NASDAQ:GRI

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial